Abstract
Objective: To describe challenges posed by COVID-19 on TB commodity supply, care cascade, active case finding, and responses taken by healthcare workers (HCWs) and community health workers (CHWs) during the first year of the pandemic (March 2020 to February 2021). Design: A qualitative descriptive study involving 25 in-depth interviews and 10 focus group discussions conducted in July 2022. Setting: 37 TB treatment facilities were purposively selected from seven regions due to high TB case notifications in 2019 and their provision of TB and COVID-19 services during the first year of the pandemic (March 2020 to February 2021). Participants: Purposive selection of 58 HCWs and 55 CHWs who provided TB services in the first year of the COVID-19 pandemic. Results: HCWs reported unusual stockouts and delayed receipt of GeneXpert cartridges and sputum containers. TB services faced a decline in client attendance, as clients were hesitant to undergo TB screening, sputum sample collection, and contact tracing due to fear of contracting or being diagnosed with COVID-19 and subsequently being quarantined. To mitigate these challenges, HCWs used alternative containers for sputum sample collection, optimized GeneXpert cartridges use by prioritizing GeneXpert testing for TB risk groups, and diagnosed TB by microscopy, chest X-ray, and sputum pooling method. Moreover, they extended drug refill schedules to minimize the risk of contracting COVID-19 in clinics. CHWs used mobile communication for client tracing and focused household visits on TB risk groups. Conclusion: COVID-19 disrupted TB commodity availability and TB treatment-seeking behavior. Adaptations like multi-month drug refills and optimized GeneXpert use, supported the TB healthcare system resilience. While these adaptations offer valuable insights for strengthening TB service delivery, their effectiveness and sustainability require further evaluation. Thus, prospective studies could clarify their long-term impact. National Tuberculosis Programs could consider adapting these practices post-pandemic, with appropriate modifications to suit different contexts. Keywords: COVID-19, Tuberculosis services, challenges, mitigations, community health workers, qualitative, healthcare workers, Tanzania
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by The Global Fund to Fight AIDS, Tuberculosis and Malaria, grant number TZA-C19RM.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Mbeya Medical Research Ethics Committee (MMREC Ref. SZEC-2439/R.A/V.1/147a) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos